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While previous research has suggested that there is an association between fluoride ingestion and 
the incidence of hypothyroidism few population level studies have been undertaken. In England 
approximately 10% of the population lives in areas with community fluoridation schemes and 
hypothyroidism prevalence can be assessed from general practice data. This observational study 
examines the association between levels of fluoride in water supplies with practice level 
hypothyroidism prevalence.  
Methods:  
We used a cross-sectional study design using secondary data to develop binary logistic regression 
models of predictive factors for hypothyroidism prevalence at practice level using 2012 data on 
fluoride levels in drinking water, 2012/13 Quality Outcomes Framework (QOF) diagnosed 
hypothyroidism prevalence data, 2013 General Practitioner (GP) registered patient numbers, and 
2012 practice level Index of Multiple Deprivation scores 
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Findings:  
We found that higher levels of fluoride in drinking water provide a useful contribution for 
predicting prevalence of hypothyroidism. We found that practices located in the West Midlands (a 
wholly fluoridated area) are nearly twice as likely to report high hypothyroidism prevalence in 
comparison to Greater Manchester (non-fluoridated area). 
Interpretation: 
In many areas of the world hypothyroidism is a major health concern and in addition to other 
factors – such as iodine deficiency – fluoride exposure should be considered as a contributing 
factor. The findings of the study raise particular concerns about the validity of community 
fluoridation as a safe public health measure. 
Funding: 





What is already known on this subject? 
• Community water fluoridation is an established public dental health intervention in some 
countries.  
• There have been a number of studies that suggest that the ingestion of fluoride is 
associated with hypothyroidism.  
• There have been no population studies that have examined this.  
• A recent analysis of health data on the impact of fluoridation in England did not examine 
hypothyroidism prevalence despite the availability of data within the national Quality and 
Outcomes Framework data set. 
 
What this study adds? 
• This study is the first population level study of the association between fluoride levels in 
water and hypothyroidism. 
• We found a positive association between fluoride levels and hypothyroidism. High 
hypothyroidism prevalence was found to be at least 30% more likely in practices located in 
areas with fluoride levels in excess of 0.3mg/L. 
• This population study supports earlier hypotheses that fluoride is associated with 
hypothyroidism. In the UK water is fluoridated at 1ppm (1mg/L) and in areas where water 
is fluoridated the model predicts that after controlling for other factors, practice 
populations are significantly more likely to have higher levels of hypothyroidism than those 
in non-fluoridated areas. Consideration needs to be given to reducing fluoride exposure 
and public dental health interventions should stop interventions reliant on ingested 
fluoride and switch to topical fluoride and non-fluoride based interventions. 
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Background  
Community water fluoridation has been an accepted public dental health intervention since its 
introduction in the USA in the 1950s.1 In England some 10% of the population receives fluoridated 
water at a target level of 1ppm (1mg/L). A recent Public Health England report evaluated a range 
of secondary health data concluding that water fluoridation is a safe public health measure.2 
However, data on hypothyroidism was not analysed in this report despite previous studies which 
have suggested that there may be a link between fluoride consumption and hypothyroidism.3  
Hypothyroidism and undetected sub-clinical hypothyroidism are associated with a number of 
health problems.3,4,5,6 While thyroid dysfunction is a common endocrine disorder there are few 
population studies that examine the association of this disease with fluoride intake.3  
In the UK, management of hypothyroidism is undertaken by primary care physicians (general 
practitioners) and patient’s thyroid function (levels of TSH and T4) is tested annually as one 
element of the GP pay-for-performance system, the Quality and Outcomes Framework (QOF).7 
This data provides a measure of practice prevalence of hypothyroidism which can be 
geographically mapped against areas with and without fluoride added to  the drinking water. This 
paper examines whether fluoride levels provide a useful contribution to a predictive model of 
practice level hypothyroidism; and whether there is any difference in hypothyroidism prevalence 
between practices serving   areas where water is fluoridated in comparison to areas not 
fluoridated.  
Approximately six million people (10%) in England live in areas where drinking water contains 
natural fluoride or which has been artificially fluoridated at a target concentration of 1ppm 
(1mg/L).2 Using prevalence data from the UK QOF, an analysis was undertaken to determine 
whether prevalence was affected by practice populations being situated in fluoridated areas at 
>0.7mg/L and areas with lower levels of fluoride. While there are other sources of fluoride in 
people’s diet (eg tea8), drinking water is the most significant source of ingested fluorides in the 
UK.9 
The effects of fluoride on the thyroid have long been observed.10 In the 1950s fluoride was used 
pharmacologically to reduce the activity of the thyroid in people with hyperthyroidism. Doctors 
selected fluoride as a thyroid suppressant based on study findings linking fluoride to goitre, and, as 
predicted, fluoride therapy did reduce thyroid activity in the treated patients.11 Typically a dose of 
between 2 to 5 mg fluoride per day was found to be effective and this is within the 
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range commonly consumed by individuals living in fluoridated areas.12,13,14 Two reviews have 
examined the impact of fluoride on  thyroid function concluding that fluoride is an endocrine 
disruptor with the potential to disrupt the function of tissues that require iodine.3,15 In particular it 
was suggested that the chief endocrine effect is decreased thyroid function at fluoride exposure 
levels as low as 0.01mg/kg/day where iodine intake is inadequate.1  The evidence relating to the 
relationship between fluoride intake and thyroid deficiency is mixed as studies either used 
observed goitre as the measure of impact or limited thyroid function measurements; or failed to 
take into account other factors, particularly inadequate iodine intake.3,15,16,17 However, studies 
suggest that the impact of fluoride on the thyroid gland is independent of iodine and that fluoride 
may in fact enhance the detrimental effect of inadequate iodine intake.3 
In most countries estimates of the prevalence of hypothyroidism depend on small scale 
epidemiological studies. Between 4% and 5% of the U.S. population may be affected by deranged 
thyroid function, making it among the most prevalent of endocrine diseases.3 In the UK, accurate 
measurement of the prevalence of hypothyroidism is possible as data on thyroid function for 
patients diagnosed with hypothyroidism has been collected by primary care physicians (general 
practitioners) since April 2004 as part of the national QOF system.7  In 2007/08 the prevalence in 
the UK was 2.8% and this increased to 3.2% by 2012/13. Prevalence data provides ‘raw 
prevalence’ (unadjusted for other factors such as age) and QOF registers may differ from other 
sources of prevalence data because of coding or definitional issues.18 However, QOF registers 
provide a reliable, universal recording of hypothyroidism status (99.7% in 2011/12) of sufficient 
quality to enable comparison of prevalence rates between practices.  
The QOF prevalence data does not account for other factors that might influence individual 
practice prevalence. Age and sex are key factors affecting hypothyroidism, prevalence being more 
common in older women and ten times more common in women than in men.19 As discussed 
above, iodine intake is an important factor in thyroid disorders. In the UK, while iodine intake 
levels have been considered adequate since the middle of the 20th Century,20 concern has been 
expressed about iodine deficiency in pregnant women and teenage girls. 21,22   
Objectives 
The aim of this study is to examine whether there are differences in prevalence of hypothyroidism 
between populations in fluoridated and non-fluoridated areas. The objective therefore was to  
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• Identify the mean and maximum fluoride levels in drinking water for practice populations 
in England 
• Assess, at a population level, whether variations in prevalence of hypothyroidism are 
associated with the fluoride levels in drinking water.  
Methods  
Study design 
We used a cross-sectional study design using secondary data to develop two binary logistic 
regression models of predictive factors for ‘high’ hypothyroidism prevalence at practice level using 
2012 data on fluoride levels in drinking water, 2012/13 QOF hypothyroidism prevalence data, 
2013 General Practitioner (GP) registered patient numbers and 2012 Index of Multiple Deprivation 
(IMD) scores for GP practices. In the first model we included all UK data; in the second we 
analysed data from two comparable built-up areas (as defined by the Office for National Statistics 
in 2011)23, one known to be fluoridated by the drinking water provider (West Midlands) and 
another known not to be fluoridated by the drinking water provider (Greater Manchester). Area 
was included as a covariate in this second model. 
Setting 
The setting was England, which had a population of 56.1 million people in 2011 with a median age 
of 39.22  
Participants 
Inclusion criteria were informed by the criteria used by Public Health England to select practices 
for inclusion in the National General Practice Profiles.24 Practices in England with a code in QOF 
2012/13 were included if they had a list size >900 which was <20% different to the number of 
patients registered on the GP Payments System as of April 2013 and if a practice level IMD score 
was available.  Additionally, GP practices were included if they could be mapped to a water supply 
zone (WSZ) using Ordnance Survey CodePoint and if fluoride levels in drinking water were 
available for that WSZ. 
Variables  
Independent variables considered for inclusion in the model were: the average (mean) 
concentration of fluoride in drinking water (mg/L), maximum concentration of fluoride in drinking 
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water (mg/L), practice level IMD scores, the proportion (%) of the practice population aged 40 and 
over and the proportion (%) of the practice population that was female. The latter two variables 
were chosen because evidence shows that hypothyroidism prevalence is greater in women and 
increases with age.17,19 Forty and over was chosen as the age cutoff as a large population study in 
Tayside, UK found that the biggest jump in hypothyroidism incidence for women was between the 
third and fourth decade.25 The dependent variable was practice level hypothyroidism prevalence. 
Data sources/measurement 
Hypothyroidism prevalence and practice list size for the period April 2012 to March 2013 were 
obtained for all GP practices in England from the QOF dataset. Practice level IMD scores were 
acquired from the Public Health England National General Practice Profiles for 2012. General 
Practice registered populations by quinary age-band and gender for April 2013 were obtained 
from the GP Payments System dataset (HSCIC) and converted to proportions of practice patients 
by female gender and those aged 40 and over. Mean and maximum fluoride concentrations were 
provided by the Drinking Water Inspectorate (DWI) based on the WSZ in which the practice 
postcode was located. It is a statutory duty for water companies to monitor water quality and 
provide corresponding data to the DWI. They monitor fluoride concentration using samples taken 
from randomly chosen consumers’ taps and/or water supply points (treatment works, service 
reservoirs and blending points). Annual sampling frequency is between one and eight for WSZ 
samples and between one and 48 for supply point monitoring; frequency is determined by local 
factors including WSZ population and average daily output of water.26 
Bias 
Potential sources of bias include: Information bias, i.e., differential water sampling frequency 
between fluoridated and non-fluoridated areas; and response and detection bias, whereby 
patients are more inclined to request a hypothyroidism test and GPs give greater consideration to 
queried hypothyroidism in fluoridated areas, are possible but unlikely. The 2014 GP Patient Survey  
shows that proportions of patients (by Clinical Commissioning Group) that saw or spoke to their 
GP (for any reason) within the last year ranges between 80% to 89%.27 This further reduces the 
likelihood that detection/response bias may influence the data. 
Statistical methods 
Data was analysed using IBM SPSS Statistics for Windows, Version 22.0 (IBM Corp, Armonk, NY, 
USA).. Practices were divided into two groups: those with low to medium hypothyroidism 
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prevalence (lower two tertiles, 0.18 : 3.57%), and high hypothyroidism prevalence (upper tertile, 
3.58 : 8.48%). The binary logistic regression models were developed to predict the likelihood of a 
practice being categorised as having recorded high levels of hypothyroidism. Variables considered 
for inclusion were: the proportion of female patients and proportion of patients aged ≥40 
registered with the practice, IMD score and WSZ fluoride levels. Proportions were entered in the 
original unit interval form and IMD score was transformed into three groups (lower, middle and 
upper tertiles). All water contains some fluoride, but fluoride levels of <0.3 mg/L are considered to 
confer no benefit to dental health.26 International consensus (USA, Canada, Ireland) for 
supplementing fluoride suggests a range of 0.7 and 1.2 mg/L should be targeted. Consequently, 
fluoride level was converted into one of three groups: low (≤ 0.3 mg/L), medium (>0.3, ≤0.7 mg/L) 
and high (>0.7 mg/L). Two alternative measures of fluoride were considered: mean fluoride 
concentrations and maximum fluoride concentrations. (see figure 1). A second model was built 
which included only practices in two built-up areas23, the West Midlands and Greater Manchester 
(see figure 1). These two areas were selected because they are demographically comparable but 
one is fluoridated by the water provider and the other is not.  
Nagelkerke, pseudo R² was used to estimate the models’ contribution to the observed variance 
and the Hosmer and Lemeshow test was used to evaluate classification. 
FIGURE 1 HERE 
Results 
Study Sample 
Of the 8,020 practices in England, data for 7935 practices (98.9%) met the criteria for inclusion. Of 
the 85 that were not included: 40 practices had list sizes <900, population data by age was missing 
for seven practices, fluoride levels were not available for 13 practices, 14 practices had a 
difference between the QOF list size and population data from GP Payments System of >20% and 










Mean ± SD 
N (number of practices) 7935 
List size (number of patients) 7022 ± 4281 
Hypothyroidism prevalence (%) 3.18 ± 1.05 
Mean fluoride (mg/L) 0.22 ± 0.27 
Maximum fluoride (mg/L) 0.28 ± 0.32 
Patients aged >40 (%) 49.0 ± 10.1 
Females (%) 49·9 ± 2·4 
Index of Multiple Deprivation score 23.84 ± 12.23 
 
Model development 
The first iteration of the model (which included mean fluoride levels) accounted for 37% of the 
observed variance and the second (which included maximum fluoride levels) was nominally better 
accounting for 37.5% of the variance (Model χ² = 2501.74 (6); p=0.000. N = 7935). The final model 
correctly predicts 75.6% of cases, which represents a useful improvement from 66.5% prediction 
rate without the covariates. Misclassification is anticipated to be unlikely (χ²=6.815 (8); p=0.557). 
All covariates were significant predictors of practice level hypothyroidism prevalence (table 2). 
After adjusting for the effects of the other covariates the model predicts that the odds of a 
practice recording high levels of hypothyroidism is 1.4 times higher in areas with maximum 
fluoride of >0.3≤0.7 mg/L and 1.6  times higher in areas with maximum fluoride in excess of 0.7 
mg/L, than it is for practices in areas with maximum fluoride ≤0.3 mg/L. For every additional 1% of 
females or 1% of people aged 40 and over registered, the odds of a practice  recording a high level 
of hypothyroidism increases by multiples of 1.2; and, the odds of a practice reporting high levels of 




Table 2: Unadjusted and adjusted odds ratios of upper tertile hypothyroidism prevalence 
according to fluoride levels in drinking water. 
 OR Fluoride level OR 95% CI 
Unadjusted   
Maximum fluoride >0.7 mg/L 1.452 1.268 : 1.662 
Maximum fluoride >0.3≤0.7 mg/L 1.711 1.439 : 2.034 
Maximum fluoride ≤0.3 mg/L    
Adjusted**   
Maximum fluoride >0.7 mg/L 1.621 1.379 : 1.904 
Maximum fluoride >0.3≤0.7 mg/L 1.371 1.120 : 1.679 
Maximum fluoride ≤0.3 mg/L    
** Adjusted for proportion of females registered with the practice, proportion of patients over 
40 years old registered with the practice, index of multiple deprivation. C-index = 0.82. 
 IMD levels from Public Health England practice profiles24 Fluoride levels from Drinking Water 
Inspectorate26 
 
The second model was restricted to data from the West Midlands and Greater Manchester. 
Maximum fluoride levels were >0.3 mg/L for all practices in the West Midlands and ≤ 0.3 mg/L in 
Greater Manchester. The model accounted for 33.7% of the observed variance. The model 
improved prediction rates from 71.4% to 76.4%. Misclassification is anticipated to be unlikely 
(χ²=2.438 (8); p=0.965). Proportion of over 40’s and females registered with the practice were 
significant predictors of practice level hypothyroidism, and had a predictive capacity similar to the 
model developed with the national level data set. The utility of IMD categories as predictors was 
reduced in this model. After adjusting for the other covariates, the built up area that a practice is 
located in is a significant predictor of practice level hypothyroidism. Practices in the West 
Midlands are have nearly twice the odds of recording a high level of hypothyroidism prevalence as 
practices in Greater Manchester (Table 3) (Model χ² = 253.788 (5); p=0.000. N = 946). 
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Table 3: Unadjusted and adjusted odds ratios of upper tertile hypothyroidism prevalence 
according to water fluoridation by provider. 
 OR Fluoride level OR 95% CI 
Unadjusted   
West Midlands (yes) 1.536 1.156 : 2.041 
Greater Manchester (no) 1   
Adjusted**   
West Midlands (yes) 1.935 1.388 : 2.699 
Greater Manchester (no) 1   
** Adjusted for proportion of females registered with the practice, proportion of patients over 
40 years old registered with the practice, index of multiple deprivation categories (16.16 - 28.4; 
28.41 – 68.36). C-index = 0.81 
IMD levels from Public Health England practice profiles24 
 
Discussion 
We hypothesized that higher levels of fluoride in drinking water would provide a useful 
contribution for predicting prevalence of hypothyroidism in a model that included other known 
predictors of elevated hypothyroidism risk (i.e., female gender and older age). Our hypothesis was 
confirmed. In addition we found a significantly higher prevalence of hypothyroidism in areas with 
high fluoride levels (>07. mg/L) compared to those with fluoride levels of 0.7 mg/L and below.  
The study assumed that fluoride levels at sampling points are representative of fluoride 
concentration for the whole WSZ and the samples take into account variance over the year. 
Ecological bias exists in the study in that it assumes that aggregated statistics i.e. GP practice 
hypothyroidism registers, are representative of the individuals living in the area. CodePoint 
location coordinates may not give a precise  location of practices as they are created by taking an 
average of the coordinates of all the individual addresses in the postcode, then snapping to the 
nearest of those addresses. The coordinates of that address are taken as representative of the 
whole postcode. Patients registered with a practice may also be distributed over a wide area, 
covering a number of WSZs and, therefore, the fluoride level for the practice postcode may not be 
 12 
accurate for practice patients. Many GP practices have branch surgeries in different geographical 
locations but the datasets do not distinguish between branch and main practices so all data is 
attributed to the main practice and thus the WSZ of the main practice. 
The analysis does not take into account sources of fluoride ingestion other than that in drinking 
water. Fluoride is found in many dental products and food and drink.3,8,9,13,14 Nevertheless, it is 
believed that drinking water is still the primary source of fluoride in England, particularly in areas 
with fluoride concentration of 1mg/L and over.9 In addition to iodine intake discussed earlier, 
perchlorate levels also affect thyroid function but recent analysis suggests levels of perchlorate in 
England are very low.28 However, the analysis does not take into account differences in 
consumption of tap water between males and females and different age groups. The National Tap 
Water Consumption Survey estimated that consumption of tap water was greater in women and 
increased with age, with those aged 40 or over consuming the most tap water.29  These estimates 
of tap water consumption did not vary greatly between the 40-54 and 55+ age groups, ranging 
from 1.4 litre per day for the former to 1.3/1.4 litres per day for the latter, therefore it is unlikely 
that these differences are significant nor do we anticipate substantial variations in consumption 
between different practice populations. While iodine intake is a key determinant of thyroid status 
the major source of iodine in the UK is from the diet and it is unlikely that there are significant 
differences between people residing in fluoridated and non-fluoridated areas.30  
Interpretation 
The clear association found in our analyses between fluoride levels in drinking water and 
variations in hypothyroidism prevalence appear to confirm findings in earlier studies that ingestion 
of fluoride affects thyroid function.1 The fact that the difference is significant suggests that there is 
substantial cause for public health concern. In England approximately six million people receive 
water containing 1mg/L of fluoride. Based on our modelling we predict that after controlling for 
other factors, practice practice populations  are significantly more likely to have higher levels of 
hypothyroidism in fluoridated areas than in non-fluoridated areas. This study only included data 
on diagnosed hypothyroidism and it is possible that in fluoridated areas there would be a 
proportion of the population who will suffer from sub-clinical hypothyroidism. While diagnosed 
hypothyroidism can be well controlled by taking thyroid supplements, there are a number of 
health problems associated with undetected sub-clinical hypothyroidism and undiagnosed 
hypothyroidism where symptoms associated with hypothyroidism are observed but not attributed 
to thyroid dysfunction.5,6,21,22 In many areas of the world hypothyroidism is a major health concern 
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and in addition to other factors – such as iodine deficiency – fluoride exposure should be 
considered as a contributing factor.  This study suggests that in fluoridated areas, testing for 
hypothyroidism should be routinely considered where any symptom attributable to lowered 
thyroid function is observed.  
Generalisability 
The finding of this cross-sectional study has important implications for public health policy in the 
UK and in other countries where fluoride is added to drinking water or in other forms such as 
fluoridated milk and salt. While in England current policy is to artificially fluoridate water at 1mg/L, 
in Canada and Southern Ireland the concentration is normally 0.7mg/L with an upper limit of 
1.2ppm. In 2011, in the USA the Department of Health and Human Sciences proposed setting a 
target concentration of 0.7mg/L but this has not yet been formally recommended and currently 
concentrations vary between 0.7mg/L and 1.3mg/L. Our study, utilizing >0.7mg/L as the threshold 
for high levels of fluoride, suggests that the results are applicable to all countries where water is 
artificially fluoridated. A recent analysis by the European Union Scientific Committee on Health 
and Environmental Risk concluded that children aged 1-6 years-old drinking 0.5L of water per day 
and children aged 6-12 years-old drinking more than 1.0L per day  with a concentration of fluoride 
of 0.8mg/L and above would exceed the recommended maximum upper limits for fluoride 
ingestion.13 This suggests that in England, given a target level of 1mg/L, particularly in areas where 
mean fluoride levels are >1.0mg/L, most children and potentially some adults will ingest excess 
fluoride.13 To minimize the risk of increasing the prevalence of hypothyroidism, it is important, 
therefore, to limit fluoride ingestion from all sources. This would be particularly important in areas 
where iodine concentrations are low, given the potential action of fluoride as an iodine inhibitor.3 
From a public health perspective this raises questions about the safety of community fluoridation 
and consideration should be given to reducing all sources of fluoride in the environment.1,13,14  
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